Single-Breath Washout Tests to Assess Small Airway Disease in COPD

Chest

Volumn 150, Issue 5, 2016, Pages 1091-1100

  Boeck, Lucas ^a   Gensmer, Anna ^b   Nyilas, Sylvia ^b,c   Stieltjes, Bram ^a   Re, Thomas J ^a   Tamm, Michael ^a   Latzin, Philipp ^b,c   Stolz, Daiana ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

COPD; lung function; physiology; small airway disease

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYSPNEA; EXERCISE; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; OXYGEN DESATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RESIDUAL VOLUME; SINGLE BREATH NITROGEN TEST; SMALL AIRWAY DISEASE; TOTAL LUNG CAPACITY; DISABILITY; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS;

EID: 84994430061     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.05.019     Document Type: Article

References (37)

1. 1 Mannino, D.M., Buist, A.S., Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370:9589 (2007), 765–773.
2. 2 Agusti, A., Calverley, P.M.A., Celli, B., et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res, 11, 2010, 122.
3. 3 Hogg, J.C., Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364:9435 (2004), 709–721.
4. 4 McDonough, J.E., Yuan, R., Suzuki, M., et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365:17 (2011), 1567–1575.
5. 5 Galbán, C.J., Han, M.K., Boes, J.L., et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 18:11 (2012), 1711–1715.
6. 6 Hogg, J.C., Macklem, P.T., Thurlbeck, W.M., Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278:25 (1968), 1355–1360.
7. 7 Robinson, P.D., Goldman, M.D., Gustafsson, P.M., Inert gas washout: theoretical background and clinical utility in respiratory disease. Respiration 78:3 (2009), 339–355.
8. 8 Robinson, P.D., Robinson, P.D., Latzin, P., et al. Consensus statement for inert gas washout measurement using multiple- and single- breath tests. Eur Respir J 41:3 (2013), 507–522.
9. 9 Cosio, M., Ghezzo, H., Hogg, J.C., et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298:23 (1978), 1277–1281.
10. 10 Singer, F., Abbas, C., Yammine, S., Casaulta, C., Frey, U., Latzin, P., Abnormal small airways function in children with mild asthma. Chest 145:3 (2014), 492–499.
11. 11 Abbas, C., Singer, F., Yammine, S., Casaulta, C., Latzin, P., Treatment response of airway clearance assessed by single-breath washout in children with cystic fibrosis. J Cyst Fibros 12:6 (2013), 567–574.
12. 12 Husemann, K., Berg, N., Engel, J., et al. Double tracer gas single-breath washout: reproducibility in healthy subjects and COPD. Eur Respir J 44:5 (2014), 1210–1222.
13. 13 Stolz, D., Kostikas, K., Blasi, F., et al. Adrenomedullin refines mortality prediction by the BODE index in COPD: the “BODE-A” index. Eur Respir J 43:2 (2014), 397–408.
14. 14 Stolz, D., Meyer, A., Rakic, J., Boeck, L., Scherr, A., Tamm, M., Mortality risk prediction in COPD by a prognostic biomarker panel. Eur Respir J 44:6 (2014), 1557–1570.
15. 15 Wanger, J., Clausen, J.L., Coates, A., et al. Standardisation of the measurement of lung volumes. Eur Respir J 26:3 (2005), 511–522.
16. 16 Pellegrino, R., Viegi, G., Brusasco, V., et al. Interpretative strategies for lung function tests. Eur Respir J 26:5 (2005), 948–968.
17. 17 Crapo, R.O., Casaburi, R., Coates, A.L., et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:1 (2002), 111–117.
18. 18 Davidson, A.C., Leach, R., George, R.J., Geddes, D.M., Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax 43:12 (1988), 965–971.
19. 19 Bestall, J.C., Paul, E.A., Garrod, R., Garnham, R., Jones, P.W., Wedzicha, J.A., Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:7 (1999), 581–586.
20. 20 Singer, F., Stern, G., Thamrin, C., et al. Tidal volume single breath washout of two tracer gases - a practical and promising lung function test. PLoS One, 6(3), 2011, e17588.
21. 21 Abramoff, M.D., Magalhaes, P.J., Ram, S.J., Abramoff: image processing with ImageJ. Biophotonics 11:7 (2004), 36–42.
22. 22 Chapman, K.R., Burdon, J.G.W., Piitulainen, E., et al. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Lancet 386:9991 (2015), 360–368.
23. 23 Lapperre, T.S., Small airways dysfunction and neutrophilic inflammation in bronchial biopsies and BAL in COPD. Chest 131:1 (2007), 53–59.
24. 24 Berend, N., Wright, J.L., Thurlbeck, W.M., Marlin, G.E., Woolcock, A.J., Small airways disease: reproducibility of measurements and correlation with lung function. Chest 79:3 (1981), 263–268.
25. 25 Van Muyleim, A., De Vuyst, P., Yernault, J.-C., Paiva, M., Inert gas single-breath washout and structural alteration of respiratory bronchioles. Am Rev Respir Dis 146:5 pt 1 (1992), 1167–1172.
26. 26 Verbanck, S., Schuermans, D., Meysman, M., Paiva, M., Vincken, W., Noninvasive assessment of airway alterations in smokers. Am J Respir Crit Care Med 170:4 (2004), 414–419.
27. 27 Verbanck, S., Schuermans, D., Paiva, M., Meysman, M., Vincken, W., Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 174:8 (2006), 853–857.
28. 28 Gennimata, S.-A., Palamidas, A., Karakontaki, F., et al. Pathophysiology of evolution of small airways disease to overt COPD. COPD 7:4 (2010), 269–275.
29. 29 Mikamo, M., Shirai, T., Mori, K., et al. Predictors of phase III slope of nitrogen single-breath washout in COPD. Respir Physiol Neurobiol 189:1 (2013), 42–46.
30. 30 Singer, F., Stern, G., Thamrin, C., et al. A new double-tracer gas single-breath washout to assess early cystic fibrosis lung disease. Eur Respir J 41:2 (2013), 339–345.
31. 31 Verbanck, S., Paiva, M., Dual gas techniques for peripheral airway function: diffusing the issues. Eur Respir J 45:5 (2015), 1491–1494.
32. 32 Gosselink, J.V., Hayashi, S., Elliott, W.M., et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:12 (2010), 1329–1335.
33. 33 Horsley, A., Lung clearance index in the assessment of airways disease. Respir Med 103:6 (2009), 793–799.
34. 34 O'Donnell, C.R., Bankier, A.A., Stiebellehner, L., Reilly, J.J., Brown, R., Loring, S.H., Comparison of plethysmographic and helium dilution lung volumes. Chest 137:5 (2010), 1108–1115.
35. 35 Dykstra, B.J., Scanlon, P.D., Kester, M.M., Beck, K.C., Enright, P.L., Lung volumes in 4,774 patients with obstructive lung disease. Chest 115:1 (1999), 68–74.
36. 36 Latzin, P., Thompson, B., Double tracer gas single-breath washout: promising for clinics or just a toy for research?. Eur Respir J 44:5 (2014), 1113–1115.
37. 37 Menkes, H.A., Beaty, T.H., Cohen, B.H., Weinmann, G., Nitrogen washout and mortality. Am Rev Respir Dis 132:1 (1985), 115–119.